FamiCord AG V3V

XETR · Germany · Health Technology

€2.97+0.01 (+0.34%)

Market closed· Oct 1, 2026, 3:35 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

FamiCord AG V3V

XETR · Germany · Health Technology

€2.97+0.01 (+0.34%)

Market closed· Oct 1, 2026, 3:35 PM UTC· EUR · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-37.08% · 6MFull-screen chart

Open €3.04High €3.04Low €2.97Close €2.97Volume 9

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: €2.96
Day range: €2.97 – €3.04
52-week range: €2.58 – €7.15
Volume: 9
Market cap: €51.60M
Next earnings date: 2026-11-30
Avg. volume (1Y): 1.89K

Performance

1 week

-1.62%

1 month

+3.75%

3 months

-13.14%

6 months

-34.76%

Year to date

-49.75%

1 year

-47.13%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Germany
Exchange: XETR
Shares outstanding: 17.43M
Employees: 742
ISIN: DE000A0BL849
Beta: 0.31

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceSep 24, 2026

FamiCord AG Wins Promising New Client for Its CDMO Activities With Manufacturing Agreement for Pivotal Phase II/III Trial With Initial Value in the low Single-digit Millions of Euros

FamiCord CDMO division selected by VERIGRAFT to establish the GMP manufacturing process for personalized tissue-engineered vein P-TEV at its Warsaw site Approximately 18-month collaboration with an estimated contract value in the low single-digi...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.